Cases admitted annually dose but combinations of drugs now account for 18% of cases compared with 5% in 1958. The report by Higgins and O'Brien (1965) has emphasised this point and we have encountered a similar range of new drugs in the past few years.
To maintain a 24 hour service four or five of the technical staff ofthe biochemistry department work a rota and our figures show that 55% of cases are admitted outside the laboratory's normal working hours. Something like half the emergency biochemical calls are now for this reason. In any planning for a Poisons Service the necessity for an adequate number of trained staff must be emphasised. The provision of apparatus too, is very important and certainly any clinical laboratory undertaking this work must have an ultra-violet spectrophotometer and it seems likely that we will require more sophisticated apparatus such as infra-red spectrophotometers to tackle the identification of newer drugs. The milky appearance of lacteals after a fat meal has been known for more than three hundred years (Rudbeck, 1653) and in 1877, Edmunds described the first dark-ground pictures of blood, mentioning the presence ofminute particles. Association of opalescent lymph with the particulate matter in plasma was not realised for a very long time and a wide variety of possibilities were suggested as to the nature of these particles. Only recently have they been proved to consist essentially of fat (Frazer and Stewart, 1937) . In certain pathological conditions, the number of these chylomicra, as the fat particles were termed by Gage and Fish (1924) , is consistently raised so that the condition of hyperlipemia exists. Although this condition may sometimes be associated with high blood cholesterollevels, hypercholestemia and hyperlipemia are not synonymous; very high cholesterol concentrations may be found frequently in clear sera and normal cholesterol levels encountered in frankly turbid sera. We have confined our studies to some aspects of hyperlipemia.
It may be postulated that hyperlipemia could be due to one or more of a number of causes. One group of possibilities is that the ingress of fat into the blood stream may be raised, the fat arising from either the diet, the fat depots including the liver, or through carbohydrate metabolism. Alternatively, the blood fat may be raised because of impaired removal of the chylomicra which normally occurs by either particulate disposal to the liver and depots, or by 'clearing' the plasma through a lipolytic process. It would seem likely that of these five possible causes of hyperlipemia, the latter is the most important.
Investigation of the clearing reaction really began just over 20 years ago when Hahn (1943) observed a decrease in turbidity of lactescent serum following intravenous heparin. Since then, the factor responsible has been identified as a lipoprotein lipase (Korn, 1955) acting on chylomicron triglyceride. This clearing factor differs from pancreatic lipase in a number of properties, particularly in that the end products of lipolysis are glycerol and free fatty acids, with the formation of lower glycerides en route, in con-TIME POST-PRANDIALLY (HRS.) trast to intestinal lipolysis which proceeds only to the monoglyceride stage (Frazer and Sammons, 1945) . Evidence whether the clearing factor plays a significant role in normal physiological processes is both sparse and conflicting. However, it has been claimed (Jefferies, 1954) that serum withdrawn during the course of alimentary hyperlipemia was able to hydrolyse chylomicron fat in vitro. Furthermore, the release of clearing factor following a fat meal can also be postulated from the initial drop in serum chylomicron counts frequently seem immediately after a fat meal as demonstrated in the chylemicrograph shown in Figure I . We interpret this observation as indicating that when fat is eaten, the whole of lipid metabolism, including clearing the blood plasma, is stimulated, but as no fat is absorbed in the first few minutes, the nett result is seen as a decrease in the number of chylomicra until the rate of absorption compensates and then exceeds the removal of plasma chylomicra.
During the routine examination of the lipid composition of various body fluids from the rat by thin-layer chromatography (TLC), it was observed that although monoglycerides were present in both intraluminar and blood lipid extracts, they were absent from simultaneously collected chyle which is the established route of triglyceride absorption. To explain this observation, it was postulated that the plasma monoglycerides are formed during the lipolytic clearing of chylomicra; no monoglycerides being found in the chyle because the intraluminar monoglycerides are re-esterified in the intestinal cell to form triglycerides (Clark and Hilbscher, 1961) which are then incorporated into chylomicra. Evidence supporting this hypothesis was obtained by studying the chemical composition of lipemic serum by TLC during both in vitro and in vivo clearing. The in vitro clearing was achieved by the addition of serum collected from a rat 15 minutes after an intravenous dose of heparin to lipemic serum or chyle from another animal. Thin-layer chromatography of the system immediately after mixing showed monoglycerides to be absent, but as clearing proceeded (as indicated by turbidity measurements) monoglycerides were formed. The in vivo test consisted of giving heparin intravenously to a patient with essential hyperlipemia, collecting blood specimens immediately before and at about 10 minutes after the heparin injection. No mono-4 glycerides were found in the pre-heparin sample, but considerable quantities were present in the second sample, the turbidity of which was 30% less than that of the other. Both experiments have since been repeated with the same results. Monoglyceride production during clearing completes the evidence for association of lipolysis with the clearing of lipemic plasma because the enzyme responsible and the release of fatty acids during that process have been known for some years. It would seem likely that if the reaction products were caused to accumulate, the forward reaction of lipolysis, and therefore clearing, would be inhibited. Robinson and French (1953) have shown that albumin acts as the acceptor for the fatty acids released during lipolysis. In nephrotics, the serum albumin may be considerably reduced. Hyperlipemia is frequently associated with nephrosis and although the plasma cholesterol may be raised above normal limits, it cannot entirely account for the lipemia. Thin-layer chromatography of plasma lipids from a number of nephrotic patients revealed a raised triglyceride fraction together with the virtual or complete absence of monoglycerides. Furthermore, one such subject (with a serum albumin of 0·8 g. %) given 40 g. butter fat with his breakfast did not produce monoglycerides in the blood plasma in the subsequent 8 hours, during which time there was an increase in the triglyceride fraction. It would appear, therefore, that the hyperlipemia of nephrotics is also due to some fault in the lipolytic clearing system.
Each of the possible causes of hyperlipemia have been summarised in Figure 2 . Of the main groups of possibilities shown on the first line, the most important is that of impaired lipolysis. This may also be due to one or more of a number of causes as indicated. Each of these possibilities has been demonstrated to occur by a number of workers, but only when much more information is available on these various causes, will it be possible to re-examine our hypothesis that the metabolic significance of hyperlipemia is mainly representative of some fault in the lipolytic clearing of chylomicra and not because of the nature of the fat entering the blood stream, nor a failure of particulate disposal to the liver or depots.
